MedReg International is a Calgary-based regulatory affairs firm that helps medical device manufacturers secure approvals across markets (US FDA, EU CE, Health Canada, UKCA, LATAM, Middle East, Asia) and stay compliant with ISO 13485. They provide a Concept to Market framework that guides early-stage devices through the development phases—from initiation and risk assessment to concept feasibility and design verification/validation—emphasizing risk management, customer requirements, and a robust QMS. Their services cover market research, intellectual property guidance, funding strategy, regulatory submissions, and internal audits to support end-to-end regulatory compliance.
AI named MedReg International from February 2026 to March 2026.